title: Ciprofloxacin: a preferred treatment for legionella infections in patients receiving cyclosporin A.
authors.forename: T L
authors.initials: TL
authors.lastname: Hooper
authors.forename: F K
authors.initials: FK
authors.lastname: Gould
authors.forename: C R
authors.initials: CR
authors.lastname: Swinburn
authors.forename: G
authors.initials: G
authors.lastname: Featherstone
authors.forename: N J
authors.initials: NJ
authors.lastname: Odom
authors.forename: P A
authors.initials: PA
authors.lastname: Corris
authors.forename: R
authors.initials: R
authors.lastname: Freeman
authors.forename: C G
authors.initials: CG
authors.lastname: McGregor
mesh_terms: D002939:Ciprofloxacin / Q000627:therapeutic use*; D003524:Cyclosporins / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D016027:Heart Transplantation; D006801:Humans; D007876:Legionellosis / Q000188:drug therapy* / Q000382:microbiology; D014184:Transplantation, Homologous
chemical_list: D003524:Cyclosporins; D002939:Ciprofloxacin